UCB's Global Corporate Website

UCB’s commitment to epilepsy

Picture of Allyson Funk, US Communications and Public Relations
Posted by
Allyson Funk, US Communications and Public Relations
Decades of research have improved the lives of people with epilepsy. However, there is still a lot of work to do to address the unmet needs of patients: One in three people with epilepsy live with uncontrolled seizures.

At UCB, we are proud to work every day to advance epilepsy care, and remain determined to help patients find answers that allow them to live seizure free. It is with this bold goal in mind that we work every day to turn scientific knowledge into solutions for patients.


Our ongoing quest to find new epilepsy medicines is highlighted as part of the  Pharmaceutical Research and Manufacturers of America’s (PhRMA) GOBOLDLY campaign. The videos feature UCB’s Henrik Klitgaard shown side-by-side with longtime epilepsy advocate Loretta.

Henrik offers hope of future breakthroughs thanks to advances in genetics and the causes of neurological disorders. Having spent his professional life in epilepsy research, he is convinced that solutions will be found.

UCB is proud to GO BOLDLY and remains committed to helping epilepsy patients live their best lives.

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.


Enter the characters shown in the image.